HIV/AIDS

Thirty years of HIV: Have we shifted our focus in the right direction?

February 22, 2012

February 7th marked 30 years of fighting HIV. We've done an outstanding job stopping the spread of infection, but what about preventing the start of disease and reducing disparities?
 

HIV/AIDS: 
Improved
 outcomes, less disparity

January 11, 2012

The goal of the National HIV/AIDS Strategy for the United States is to rededicate attention to HIV/AIDS management in the areas of prevention, outcome improvement, and elimination of disparities.
 

AIDS: We've come a long way, but in some ways we've barely made a dent

November 15, 2011

The Academy's Health Disparities Work Group recommends specific strategies physician assistants can adopt to encourage their patients to undergo testing for HIV, as the Centers for Disease Control and Prevention recommends.
 

Postexposure prophylaxis for HIV: Pivotal intervention for those at risk

, Denise Rizzolo, PA-C, PhD August 03, 2011

Postexposure prophylaxis is about 81% effective in preventing seroconversion to acute HIV infection. But when is it appropriate, how is it executed, and what follow-up is needed?
 

Toxoplasmosis and malaria

May 18, 2011

This article reviews the general features, clinical assessment, diagnosis, and treatment of toxoplasmosis and malaria.
 

HIV exceptionalism and ethical 
concerns surrounding HIV testing

April 28, 2011

As medical and public health professionals, PAs are sworn to do no harm, but the varied ways to obtain consent for HIV testing challenge this oath.
 

Miller Fisher variant of Guillain-Barré syndrome in an HIV-infected patient

, Miguel Valdes-Sueiras, MD; Pam Jongthavorn, NP; Shilpa Sayana, MD; Homayoon Khanlou, MD March 07, 2011

Symptom overlap makes Miller Fisher syndrome hard to distinguish, but the presence of antiganglioside antibodies can verify a diagnosis.
 

Initiating HIV antiretroviral therapy: Criteria, evidence, and controversy

February 02, 2011

Based on efficacy data, durability of viral suppression, and ease of use, four combination regimens are preferred for starting HAART.
 

Should my son get an HPV vaccine?

, Rebecca Buckley, MHS, PA-C January 25, 2011

This information can help PAs understand the risks and benefits of HPV vaccines, enabling them to explain to parents and patients the importance of the vaccine, particularly in adolescent males.
 

Attitudes of US physician assistants toward persons with HIV/AIDS

, Kyrie Ritzdorf, MPA, PA-C; Richard D. Muma, PhD, MPH, PA-C December 23, 2010

The PAs surveyed for this study had supportive attitudes toward patients with HIV/AIDS, but further research is needed to learn whether this view extends to the profession as a whole.
 

Eliminating health disparities: What works?—April 2010

April 22, 2010

This column examines recent literature on health disparities, emphasizing tools that can help clinicians to assess and address disparities in their own practices. This month's listings focus on obesity and HIV care.
 

What's New in HIV/AIDS: Treatment Immune reconstitution inflammatory syndrome (IRIS) can complicate management of patients on antiretroviral therapy.

, Tara Gleaves, PA-C, MHS; Michelle R. Salvaggio, MD, FACP December 10, 2009

What's new in HIV AIDS treatment? Immune reconstitution inflammatory syndrome is associated with recovering immune status and can make patients susceptible to infection.
 
 

Growing old with HIV: The AIDS epidemic and an aging population

Jeffrey D. Myers, PA-C, MMSc, MIH January 01, 2009

Effective therapy and a more active older lifestyle are changing the demographic of infected patients.
 

Papulosquamous rash in a man with HIV disease

W. Patrick Bowden, MMS, RPA-C; Cynthia H. Miller, MD August 01, 2007

A 41-year-old Colombian male visited an urgent care facility complaining of a chronic, nonproductive cough. he was tested positive for HIV. One month later, the patient came to the emergency department with a cough, a fever, and malaise. He was noted to have a generalized papulosquamous rash over most of his body.
 

On the front lines of caring for people with AIDS

September 01, 2005

Between 1978 and 1980, a cohort of 6,875 homosexual men were studied at the University of California, San Francisco, to determine the incidence and prevalence of a new T-lymph tropic virus, type III/lymphadenopathy-associated virus (HTLV-III/LAV), which was later called human immunodeficiency virus (HIV).
 

© 2012 American Academy of Physician Assistants and Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions